Statins increase the risk of prostate cancer: A population-based case-control study

The Prostate, 04/13/2011

The examination of 388 prostate cancer cases and 1,552 controls in the study shows that ever–use of any statin was associated with a significant increase in prostate cancer risk. Compared with no use of statins, the adjusted odds ratios (ORs) were 1.17 for the group with cumulative dose =<29.44 DDD, 1.59 for the group with cumulative dose between 29.44 DDD and 321.33 DDD, and 1.86 for the group with the highest cumulative dose. There was a significant trend toward increasing prostate cancer risk with increasing cumulative dose.

Print Article Summary Cat 2 CME Report